Alfred Sandrock, President and CEO at Voyager Therapeutics, Inc. (VYGR), sold 24,230 shares at $9.86 ($239K) on 2024-04-02, disclosed to the SEC on 2024-04-03.
Open-market sale of $239k VYGR by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.86 | 12,115 | $119K | 50.0% |
| 2 | $9.86 | 12,115 | $119K | 50.0% |
| Total | $9.86 avg | 24,230 | $239K | 100% |
| Filing → |
| VYGR | SELL | 2026-02-20 | $40K | — | Filing → |
| VYGR | SELL | 2026-02-11 | $46K | — | Filing → |
| VYGR | SELL | 2025-04-04 | $37K | — | Filing → |